Wells Fargo & Company Increases Doximity (NASDAQ:DOCS) Price Target to $43.00

Doximity (NASDAQ:DOCS) had its price target raised by investment analysts at Wells Fargo & Company from $41.00 to $43.00 in a report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target would suggest a potential downside of 15.15% from the company’s previous close.

DOCS has been the topic of a number of other research reports. Baird R W upgraded Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and increased their target price for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Bank of America increased their target price on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Truist Financial increased their target price on Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Finally, Evercore ISI raised their price objective on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Thirteen equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $53.12.

Doximity Trading Up 2.0 %

Shares of NASDAQ DOCS opened at $50.68 on Monday. The firm has a market cap of $9.46 billion, a P/E ratio of 58.25, a price-to-earnings-growth ratio of 4.13 and a beta of 1.38. Doximity has a 1-year low of $22.96 and a 1-year high of $61.75. The business’s 50 day moving average is $53.40 and its 200-day moving average is $42.09.

Institutional Investors Weigh In On Doximity

Large investors have recently modified their holdings of the business. GAMMA Investing LLC boosted its holdings in shares of Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock valued at $93,000 after acquiring an additional 296 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in shares of Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after acquiring an additional 363 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after acquiring an additional 384 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after acquiring an additional 603 shares in the last quarter. Finally, KBC Group NV boosted its holdings in shares of Doximity by 22.9% during the 3rd quarter. KBC Group NV now owns 3,296 shares of the company’s stock valued at $144,000 after acquiring an additional 614 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.